by Eric Morse, MD; Graeme Christianson, BSE; Melissa Olivadoti, PhD; and John Timberlake, MBA Dr. Morse is with Carolina Performance in Raleigh, North Carolina and Morse Clinics in Raleigh, North
by Jon C. Martin, DO, and Danielle Gainer, MD Dr. Martin is with Wright Patterson Medical Center in Wright-Patterson Air Force Base, Ohio. Dr. Gainer is with Wright State University
By Adegboyega Oyemade, MD, FAPA Funding/financial disclosures. The author has no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this
Dear Editor: Marijuana is one of the most common illegal drugs consumed in the United States. Its use is growing in popularity, especially among young people, partly because of increasing
by Shahid Ali, MD; Barira Tahir, MD; Shagufta Jabeen, MD; and Madeeha Malik Drs. Ali and Tahir are with the Smart Choice Treatment Center in Franklin, Tennessee. Ms. Malik is
by Zeinab Ebrahimian, MSc; Zeinab Karimi, MSc; Mohammad Javad Khoshnoud, Pharm D, PhD; Mohammad Reza Namavar, PhD; Bahram Daraei, PharmD, PhD; and Moshen Raza Haidari, MD, PhD Drs. Ebrahimian and
by Malathi Latha Perugula, MD, and Steven Lippmann, MD The authors are from the Department of Psychiatry and Behavioral Science, University of Louisville School of Medicine, Louisville, Kentucky. Innov Clin
Innov Clin Neurosci. 2016;13(7–8):13–14. Dear Editor: Substance use disorders frequently coexist with and complicate the treatment of mood and anxiety disorders. Gabapentin is one of the most commonly prescribed off-label
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
by Kai MacDonald, MD, and Katherine Pappas, BA Dr. MacDonald and Ms. Pappas are with UC San Diego Psychiatry, San Diego, CA, USA Innov Clin Neurosci. 2016;13(3–4):13–22. Funding: Dr. MacDonald’s
by Murali K. Kolikonda, MD; Kavitha Srinivasan, MD; Manasa Enja, MD; Vishwanath Sagi, MD; and Steven Lippmann, MD Drs. Kolikonda and Sagi are from the Department of Neurology, Dr. Srinivasan
Dear Editor: The frequent emergence of new illicit drugs and the ever-evolving trends in their use continue to cause difficulties for clinicians in regard to screening, detection, and treatment and
by Masaru Nakamura, MD, PhD; Megumi Seki, MD; Yosuke Sato, MD; and Takahiko Nagamine, MD, PhD Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Dr. Seki is with
by Dharmendra Goyal, MBBS; Sandarsh Surya, MBBS; Joshua Elder, MD; William V. McCall, MD; and Krystle Graham, DO All authors are with the Department of Psychiatry and Health Behavior, Medical
by Farid Talih, MD, and Jean Ajaltouni, MD Dr. Talih is an assistant professor and Dr. Ajaltouni is a research fellow at the American University of Beirut Medical Center Department
Dear Editor: An estimated 75 million Americans experience nonmalignant chronic pain,[1] and oftentimes the responsibility for management falls to the primary care provider. Therefore, pain management is an increasingly important
The latest in neuroscience—sorted and summarized for you Welcome to the Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
by Murali K. Kolikonda, MD; Suneela Cherlopalle, MD; Manasa Enja, MD; and Steven Lippmann, MD Drs. Kolikonda, Cherlopalle, Enja, and Lippmann are with the University of Louisville School of Medicine,
by Randy A. Sansone, MD, and Lori A. Sansone, MD R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine
When the Opioid Medications Go Missing: Confidentiality and Safety in Adolescents
by Muhammad Hassan Majeed, MD Dr. Majeed is an Attending Psychiatrist at Natchaug Hospital, Norwich, Connecticut. Innov Clin Neurosci. 2017;14(5–6):25–27 Funding: No funding was received for the preparation of this
Read More